A citation-based method for searching scientific literature

Cristina Mitric, Marcus Q Bernardini. Curr Oncol 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms.
Andreas Venizelos, Hege Elvebakken, Aurel Perren, Oleksii Nikolaienko, Wei Deng, Inger Marie B Lothe, Anne Couvelard, Geir Olav Hjortland, Anna Sundlöv, Johanna Svensson,[...]. Endocr Relat Cancer 2021
11
100

Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.
Nobuyuki Ohike, Ipek Coban, Grace E Kim, Olca Basturk, Takuma Tajiri, Alyssa Krasinskas, Sudeshna Bandyopadhyay, Toshio Morohoshi, Yuki Shimada, David A Kooby,[...]. Am J Surg Pathol 2010
70
100

Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors.
Ahmad Al-Hader, Rami N Al-Rohil, Haiyong Han, Daniel Von Hoff. World J Gastroenterol 2017
35
100

Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different?
Claudio Luchini, Robert C Grant, Aldo Scarpa, Steven Gallinger. Gut 2021
11
100

Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications.
Concetta Sciammarella, Maria Bencivenga, Andrea Mafficini, Maria L Piredda, Vassilena Tsvetkova, Gaetano Paolino, Maria G Mastrosimini, Selma Hetoja, Giovanni de Manzoni, Paola Mattiolo,[...]. Appl Immunohistochem Mol Morphol 2022
2
100


Long Survival and Prolonged Remission after Surgery and Chemotherapy in a Metastatic Mismatch Repair Deficient Pancreatic Neuroendocrine Carcinoma with MLH1/PMS2 Immunodeficiency and Minimal Microsatellite Shift.
Alessandro Vanoli, Vittorio Perfetti, Daniela Furlan, Giuseppe Neri, Alessandra Viglio, Fausto Sessa, Michele Martino, Antonio Di Sabatino, Enrico Solcia, Stefano La Rosa. Endocr Pathol 2020
3
100


Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis.
Claudio Luchini, Nicola Veronese, Alessia Nottegar, Giulio Riva, Camilla Pilati, Andrea Mafficini, Brendon Stubbs, Michele Simbolo, Aldo Mombello, Vincenzo Corbo,[...]. Pancreas 2019
6
100

Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
P S Moore, S Orlandini, G Zamboni, P Capelli, G Rigaud, M Falconi, C Bassi, N R Lemoine, A Scarpa. Br J Cancer 2001
146
100

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.
Aurelien Marabelle, Dung T Le, Paolo A Ascierto, Anna Maria Di Giacomo, Ana De Jesus-Acosta, Jean-Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R Hansen,[...]. J Clin Oncol 2020
768
100

Treatment Approach to Adenocarcinoma of the Ampulla of Vater.
Monica Patel, Nataliya V Uboha. Curr Treat Options Oncol 2021
2
100

RET gene rearrangements occur in a subset of pancreatic acinar cell carcinomas.
Angela Chou, Ian S Brown, M Priyanthi Kumarasinghe, Aurel Perren, Denise Riley, Yoomee Kim, Marina Pajic, Angela Steinmann, Vivek Rathi, Nigel B Jamieson,[...]. Mod Pathol 2020
11
100

Metastatic Pancreatic Cancer: ASCO Guideline Update.
Davendra P S Sohal, Erin B Kennedy, Pelin Cinar, Thierry Conroy, Mehmet S Copur, Christopher H Crane, Ignacio Garrido-Laguna, Michelle W Lau, Tyler Johnson, Smitha Krishnamurthi,[...]. J Clin Oncol 2020
65
100

An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN).
Aasems Jacob, Rishi Raj, Derek B Allison, Heloisa P Soares, Aman Chauhan. Curr Treat Options Oncol 2022
1
100


Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.
Zishuo I Hu, Jinru Shia, Zsofia K Stadler, Anna M Varghese, Marinela Capanu, Erin Salo-Mullen, Maeve A Lowery, Luis A Diaz, Diana Mandelker, Kenneth H Yu,[...]. Clin Cancer Res 2018
191
100

Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic review.
Daniel M Girardi, Andrea C B Silva, Juliana Florinda M Rêgo, Renata A Coudry, Rachel P Riechelmann. Cancer Treat Rev 2017
43
100

Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
Yue Xue, Michelle D Reid, Serdar Balci, Brian Quigley, Takashi Muraki, Bahar Memis, Jun Xia, Ezgi Hacihasanoglu, Gabriela Bedolla, Burcin Pehlivanoglu,[...]. Am J Surg Pathol 2017
18
100

Simulation-based analyses reveal stable microsatellite sequences in human pancreatic cancer.
Kei Fujii, Kaname Miyashita, Yu Yamada, Takashi Eguchi, Ken-ichi Taguchi, Yoshinao Oda, Shinya Oda, Mitsuaki A Yoshida, Masao Tanaka, Masazumi Tsuneyoshi. Cancer Genet Cytogenet 2009
12
100

Molecular pathogenesis of sporadic duodenal cancer.
A Achille, A Baron, G Zamboni, S Orlandini, G Bogina, C Bassi, C Iacono, A Scarpa. Br J Cancer 1998
28
100

Cancers of the papilla of vater: mutator phenotype is associated with good prognosis.
A Achille, M O Biasi, G Zamboni, G Bogina, C Iacono, G Talamini, G Capella, A Scarpa. Clin Cancer Res 1997
51
100

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.
A B Schrock, C Ouyang, J Sandhu, E Sokol, D Jin, J S Ross, V A Miller, D Lim, I Amanam, J Chao,[...]. Ann Oncol 2019
209
100

Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy.
Maeve A Lowery, David S Klimstra, Jinru Shia, Kenneth H Yu, Peter J Allen, Murray F Brennan, Eileen M O'Reilly. Oncologist 2011
81
100


A FISH assay efficiently screens for BRAF gene rearrangements in pancreatic acinar-type neoplasms.
Lu Wang, Olca Basturk, Jiajing Wang, Ryma Benayed, Sumit Middha, Ahmet Zehir, Irina Linkov, Mamta Rao, Ruth Aryeequaye, Long Cao,[...]. Mod Pathol 2018
11
100

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.
Daniel J Sargent, Silvia Marsoni, Genevieve Monges, Stephen N Thibodeau, Roberto Labianca, Stanley R Hamilton, Amy J French, Brian Kabat, Nathan R Foster, Valter Torri,[...]. J Clin Oncol 2010
961
100

Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis.
A Scarpa, C Di Pace, G Talamini, M Falconi, N R Lemoine, C Iacono, A Achille, A Baron, G Zamboni. Gut 2000
37
100

Differential clinicopathological features in microsatellite instability-positive colorectal cancers depending on CIMP status.
Jeong Mo Bae, Mi Jung Kim, Jung Ho Kim, Jae Moon Koh, Nam-Yun Cho, Tae-You Kim, Gyeong Hoon Kang. Virchows Arch 2011
38
100

Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer.
Jinru Shia, Nathan A Ellis, Philip B Paty, Garrett M Nash, Jing Qin, Kenneth Offit, Xin-Min Zhang, Arnold J Markowitz, Khedoudja Nafa, Jose G Guillem,[...]. Am J Surg Pathol 2003
165
100


Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
Luis A Diaz, Kai-Keen Shiu, Tae-Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, Cornelis Punt, Denis Smith, Rocio Garcia-Carbonero, Manuel Benavides, Peter Gibbs,[...]. Lancet Oncol 2022
7
100

Multivariate analysis of immunohistochemical evaluation of protein expression in pancreatic ductal adenocarcinoma reveals prognostic significance for persistent Smad4 expression only.
Niki A Ottenhof, Folkert H M Morsink, Fiebo Ten Kate, Cornelis J F van Noorden, G Johan A Offerhaus. Cell Oncol (Dordr) 2012
26
100

Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma.
Maziar Riazy, Steve E Kalloger, Brandon S Sheffield, Renata D Peixoto, Hector H Li-Chang, Charles H Scudamore, Daniel J Renouf, David F Schaeffer. Mod Pathol 2015
35
100

Ampulla of Vater carcinoma: Molecular landscape and clinical implications.
Antonio Pea, Giulio Riva, Riccardo Bernasconi, Elisabetta Sereni, Rita Teresa Lawlor, Aldo Scarpa, Claudio Luchini. World J Gastrointest Oncol 2018
18
100

Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Renato M Lupinacci, Anastasia Goloudina, Olivier Buhard, Jean-Baptiste Bachet, Raphaël Maréchal, Pieter Demetter, Jérôme Cros, Armelle Bardier-Dupas, Ada Collura, Pascale Cervera,[...]. Gastroenterology 2018
52
100

Pancreatic Ductal Adenocarcinoma and Its Variants.
Claudio Luchini, Paola Capelli, Aldo Scarpa. Surg Pathol Clin 2016
64
100

Association between molecular subtypes of colorectal cancer and patient survival.
Amanda I Phipps, Paul J Limburg, John A Baron, Andrea N Burnett-Hartman, Daniel J Weisenberger, Peter W Laird, Frank A Sinicrope, Christophe Rosty, Daniel D Buchanan, John D Potter,[...]. Gastroenterology 2015
273
100

Frequency and clinicopathologic associations of DNA mismatch repair protein deficiency in ampullary carcinoma: Routine testing is indicated.
Yue Xue, Serdar Balci, Cisel Aydin Mericoz, Orhun C Taskin, Hongmei Jiang, Burcin Pehlivanoglu, Takashi Muraki, Bahar Memis, Burcu Saka, Grace E Kim,[...]. Cancer 2020
6
100

DNA mismatch repair abnormalities in acinar cell carcinoma of the pancreas: frequency and clinical significance.
Weiguo Liu, Jinru Shia, Mithat Gönen, Maeve A Lowery, Eileen M O'Reilly, David S Klimstra. Pancreas 2014
25
100

Refining targeted therapeutic approaches in pancreatic cancer: from histology and molecular pathology to the clinic.
Paola Mattiolo, Valentyna Kryklyva, Lodewijk A Brosens, Andrea Mafficini, Rita T Lawlor, Michele Milella, Aldo Scarpa, Vincenzo Corbo, Claudio Luchini. Expert Opin Ther Targets 2022
2
100

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
100

Extranodal extension in N1-adenocarcinoma of the pancreas and papilla of Vater: a systematic review and meta-analysis of its prognostic significance.
Claudio Luchini, Nicola Veronese, Antonio Pea, Giuseppe Sergi, Enzo Manzato, Alessia Nottegar, Marco Solmi, Paola Capelli, Aldo Scarpa. Eur J Gastroenterol Hepatol 2016
31
100

Approaches to Biopsy and Resection Specimens from the Ampulla.
Yue Xue, Michelle D Reid. Surg Pathol Clin 2020
3
100

Prognostic factors of non-ampullary duodenal adenocarcinoma.
Teijiro Hirashita, Masayuki Ohta, Kazuhiro Tada, Kunihiro Saga, Hiroomi Takayama, Yuichi Endo, Hiroki Uchida, Yukio Iwashita, Masafumi Inomata. Jpn J Clin Oncol 2018
4
100

A case of pancreatic neuroendocrine carcinoma with a favorable clinical response to pembrolizumab.
Taro Kogami, Tomohisa Iwai, Mitsuhiro Kida, Kosuke Okuwaki, Rikiya Hasegawa, Takahiro Kurosu, Masafumi Watanabe, Masahiro Matsushita, Kana Imawari, Kai Adachi,[...]. Clin J Gastroenterol 2021
1
100

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Asad Umar, C Richard Boland, Jonathan P Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralane M Lindor, Lawrence J Burgart, Richard Hamelin,[...]. J Natl Cancer Inst 2004
100

Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma.
Shinichi Yachida, Laura D Wood, Masami Suzuki, Erina Takai, Yasushi Totoki, Mamoru Kato, Claudio Luchini, Yasuhito Arai, Hiromi Nakamura, Natsuko Hama,[...]. Cancer Cell 2016
92
100

Pancreatic cancer.
Jonathan D Mizrahi, Rishi Surana, Juan W Valle, Rachna T Shroff. Lancet 2020
500
100

Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma.
Robert C Grant, Robert Denroche, Gun Ho Jang, Klaudia M Nowak, Amy Zhang, Ayelet Borgida, Spring Holter, James T Topham, Julie Wilson, Anna Dodd,[...]. Gut 2021
31
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.